drugset / Trial / NCT00967070

Skin Sensitization Potential of a New Nicotine Patch

NCT00967070

Phase 1 Completed 257 enrolled McNeil AB
RandomizedSingle-groupDouble-blindScreening

Summary

An investigation on the skin sensitization potential of a new nicotine patch. Evaluation of the potential of a new nicotine transdermal patch to cause sensitization in the skin after repeated applications.

Timeline

Start
2005-05
Primary completion
2005-08
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 25 mg Other

Indications

No indication recorded.